JAMA Oncology : Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
24.10.2024
0:00
20:41
Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.
Related Content:
Flere episoder fra "JAMA Network"
Gå ikke glip af nogen episoder af “JAMA Network” - abonnér på podcasten med gratisapp GetPodcast.